Assessment of the role of neutrophils on the antitumor effect of TNFα in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats

被引:19
作者
Manusama, ER
Nooijen, PTGA
Stavast, J
de Wilt, JHW
Marquet, RL
Eggermont, AMM
机构
[1] Univ Rotterdam Hosp, Dr Daniel Den Hoed Canc Ctr, Dept Surg, NL-3008 AE Rotterdam, Netherlands
[2] Univ Nijmegen, Dept Pathol, Nijmegen, Netherlands
关键词
oncology; chemotherapy;
D O I
10.1006/jsre.1997.5256
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction. Isolated limb perfusion (ILP) with TNF alpha in combination with melphalan and IFN gamma has resulted in an immediate and dramatic tumor response in patients. Such an effect was also noted following ILP in a rat sarcoma model. This model enables us to investigate several factors responsible for the TNF alpha-induced tumor responses. We applied total body irradiation (TBI) to reduce white blood cell count, to investigate the contribution of leukocytes to the antitumor effect of TNF alpha. Methods. Small fragments of the nonimmunogenic BN 175 sarcoma were implanted sc in the lower hind leg. A 5 Gy TBI was performed before ILP at a tumor diameter of approximately 15 mm. The hind limbs of 63 rats were perfused and were divided into 6 groups: group 1, sham perfusion, n = 9; group 2, TBI + sham perfusion, n = 6; group 3, TNF alpha 50 mu g, n = 9; group 4, melphalan 40 mu g, n = 9; group 5, TNF alpha 50 mu g + melphalan 40 mu g, n = 22; group 6, TBI + TNF alpha + melphalan ILP, n = 8. In addition, 10 rats were perfused for histological analysis at 24 h post-ILP. Results. We observed in Group 1: 9/9 progressive disease (PD); Group 2: 6/6 PD; Group 3: 9/9 PD; Group 4: 9/9 no change (NC) of tumor diameter for at least 4 days; Group 5: 6/22 NC, 16/22 complete remission (CR), 12/16 of which showed skin necrosis at the tumor site; and Group 6: 7/8 NC and 1/8 CR (without skin necrosis). After TBI, WBC reduction of 80-95% was observed, while the number of platelets was not significantly reduced and platelet aggregation was maintained at 72 %. Histological analysis revealed decreased hemorrhagic necrosis associated with the absence of PMN infiltration at the tumor margins in the TBI rats. Conclusion. TBI and the associated reduction in WBC count decreased the tumor response by TNF alpha and melphalan significantly and abrogated the immediate response of skin necrosis at the tumor site, as found in rats treated with TNF alpha and melphalan without TBI, These data strongly suggest that leukocytes play an important role in the hemorrhagic effects of TNF alpha. (C) 1998 Academic Press.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 34 条
[1]  
ALATTIYAH R, 1992, CLIN EXP IMMUNOL, V88, P537
[2]  
BANCROFT DJ, 1986, THEORY PRACTICE HIST, P402
[3]   RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
FIERS, W ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4533-4537
[4]   RESPECTIVE ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND THEIR INTEGRINS (CD-11/18) IN THE LOCAL OR SYSTEMIC TOXICITY OF LIPOPOLYSACCHARIDE [J].
CHANG, HR ;
VESIN, C ;
GRAU, GE ;
POINTAIRE, P ;
ARSENIJEVIC, D ;
STRATH, M ;
PECHERE, JC ;
PIGUET, PF .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 53 (06) :636-639
[5]   INDUCTION AND DETECTION OF A HUMAN-ENDOTHELIAL ACTIVATION ANTIGEN INVIVO [J].
COTRAN, RS ;
GIMBRONE, MA ;
BEVILACQUA, MP ;
MENDRICK, DL ;
POBER, JS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (02) :661-666
[6]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
[7]  
DVORAK HF, 1988, AM J PATHOL, V133, P95
[8]  
Eggermont A, 1994, EUR J SURG ONCOL, V20, P403
[9]   Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [J].
Eggermont, AMM ;
Koops, HS ;
Lienard, D ;
Kroon, BBR ;
vanGeel, AN ;
Hoekstra, HJ ;
Lejeune, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2653-2665
[10]  
EGGERMONT AMM, 1990, TUMOR NECROSIS FACTO, P239